Comprehensive review of recent milestones highlights statistically significant efficacy in prostate cancer prevention, discovery of novel ...
Novartis to seek full FDA approval for IgAN drug Vanrafia despite missing ph. 3 kidney function goal
It’s déjà vu all over again. Just as the kidney disease space becomes increasingly competitive, Novartis has found itself intending to turn a statistical miss into a regulatory win. | It’s déjà vu all ...
The recent presentation of the long-term results of the JCOG0802 phase 3 trial has sparked discussion within the international thoracic surgical community. Initial 5-year results in 2022 reported a ...
Find out more about how psychotic experiences may influence early brain ageing and what this means for future mental health.
A phase 2 asthma study of Upstream Bio’s TSLP receptor agonist has hit its primary endpoint. But with only the 12-week ...
The iShares Core S&P Mid-Cap ETF tracks the S&P MidCap 400 Index, selecting 400 stocks ranked #601-900 from the broader S&P ...
Reporting quality in clinical research is critical for evidence-based medicine and reproducibility of clinical studies. Previous work has mostly focused on the reporting quality of clinical trials and ...
Posterior tibial tendon dysfunction is a leading cause of adult-acquired flatfoot deformity and is often associated with chronic pain, instability, and functional decline. Surgical reconstruction ...
Background Layoffs may affect the health of those who lose their jobs as well as those who remain employed. Existing studies ...
Bitcoin is rated 'Strong Buy' due to robust network value, user growth, and an attractive current entry point. Read what investors need to know.
The combination of decitabine (DAC) and cytarabine, acclarithromycin, and granulocyte colony-stimulating factor (CAG) vs CAG alone showed greater efficacy among older patients with acute myeloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results